Rephonic
Artwork for Hematologic Oncology Update

Hematologic Oncology Update

Dr. Neil Love
Multiple Myeloma
Chronic Lymphocytic Leukemia
CAR T-Cell Therapy
Follicular Lymphoma
Non-Hodgkin Lymphoma
Bispecific Antibodies
Venetoclax
BTK Inhibitors
Myelofibrosis
Clinical Trials
Acute Myeloid Leukemia
Immune Thrombocytopenia
Chronic Myeloid Leukemia
Mantle Cell Lymphoma
Daratumumab
CAR T Therapy
Diffuse Large B-Cell Lymphoma
FDA Approval
Cytokine Release Syndrome
Tyrosine Kinase Inhibitors

Featuring one-on-one interviews conducted by Dr Neil Love, this series provides medical oncologists with access to an array of important perspectives and information on relevant advances in the treatment of hematologic cancer to facilitate optimal patient care.

PublishesWeeklyEpisodes545Founded18 years ago
Number of ListenersCategories
MedicineHealth & FitnessScience

Listen to this Podcast

Artwork for Hematologic Oncology Update

Latest Episodes

Featuring perspectives from Dr Christopher Flowers, Dr Matthew Lunning, Dr Sonali M Smith and Dr Brad S Kahl, moderated by Dr Kahl, including the following topics:

• Rational Incorporation of CD79b-Targeted Antibody-Drug Conjugates into the Manageme... more

Featuring perspectives from Dr Courtney D DiNardo and Dr Harry Paul Erba, including the following topics:

• Introduction (0:00)

• Current Management Approaches for FLT3- and IDH-Mutated Acute Myeloid Leukemia (AML) — Dr DiNardo (9:44)

• Current and ... more

YouTube

Featuring perspectives from Dr Anthony M Hunter and Dr Abdulraheem Yacoub, including the following topics:

• Introduction (0:00)

• Systemic Mastocytosis — Dr Hunter (9:33)

• Myelofibrosis — Dr Yacoub (29:40)

CME information and select publications

YouTube

Featuring perspectives from Dr Hans Lee and Dr Noopur Raje, including the following topics:

• Introduction (0:00)

• Integrating Chimeric Antigen Receptor T-Cell Therapy and Bispecific Antibodies into the Management of Relapsed/Refractory Multiple My... more

YouTube

Key Facts

Accepts Guests
Contact Information
Podcast Host
Number of Listeners
Find out how many people listen to this podcast per episode and each month.

Similar Podcasts

People also subscribe to these shows.

Two Onc Docs
Two Onc DocsSam and Karine
Blood Cancer Talks
Blood Cancer TalksRajshekhar Chakraborty, Ashwin Kishtagari, and Edward Cliff
Blood Podcast
Blood PodcastAmerican Society of Hematology
The Hematologist
The HematologistThe Hematologist

Recent Guests

Tony Hunter
Dr. Tony Hunter, Winship Cancer Institute, Emory University
Winship Cancer Institute, Emory University
Episode: Myelofibrosis and Systemic Mastocytosis — Fifth Annual National General Medical Oncology Summit
Abe Yacoub
Dr. Abe Yacoub, University of Kansas Cancer Center
University of Kansas Cancer Center
Episode: Myelofibrosis and Systemic Mastocytosis — Fifth Annual National General Medical Oncology Summit
Mian Hussein
Dr. Mian Hussein, Florida Cancer Specialists
Florida Cancer Specialists
Episode: Myelofibrosis and Systemic Mastocytosis — Fifth Annual National General Medical Oncology Summit
Dr. John Allan
From Weill Cornell Medicine, New York City
Weill Cornell Medicine
Episode: Chronic Lymphocytic Leukemia — Fifth Annual National General Medical Oncology Summit
Dr. Adam Kittai
From Perlmutter Cancer Center, New York City
Perlmutter Cancer Center
Episode: Chronic Lymphocytic Leukemia — Fifth Annual National General Medical Oncology Summit
Dr. Sue Smitha-Apori
From Florida Cancer Specialists, Inverness, FL
Florida Cancer Specialists
Episode: Chronic Lymphocytic Leukemia — Fifth Annual National General Medical Oncology Summit
Manali Kamdar
Faculty from the University of Colorado Cancer Center
University of Colorado Cancer Center
Episode: Diffuse Large B-Cell Lymphoma and Follicular Lymphoma — Fifth Annual National General Medical Oncology Summit
Krish Patel
Faculty from the Sarah Cannon Research Institute
Sarah Cannon Research Institute
Episode: Diffuse Large B-Cell Lymphoma and Follicular Lymphoma — Fifth Annual National General Medical Oncology Summit
Gilles Salles
Faculty from Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center
Episode: Diffuse Large B-Cell Lymphoma and Follicular Lymphoma — Fifth Annual National General Medical Oncology Summit

Host

Dr. Neil Love
Lead interviewer and host across multiple series and episodes, focused on hematology-oncology topics and CME-driven education.

Reviews

4.6 out of 5 stars from 131 ratings
  • A debt of gratitude that cannot be repaid

    That is how I feel about Dr Neil Love and his tireless work in continuing medical education for everyone in the medical field. These podcasts and discussions contained are informative, thought provoking and provide and excellent in depth but quick update in the rapidly ever-changing field of Hematology-Oncology.

    Apple Podcasts
    5
    Bongir
    United States3 years ago
  • Excellent content

    Always informative, always applies to those of us on the ground making difficult daily decisions on management in the community. Often with limited resources.

    Apple Podcasts
    5
    ZomBucker
    United States4 years ago
  • Excellent up to date reviews.

    I

    Apple Podcasts
    5
    IanMack5000
    United States15 years ago

Listeners Say

Key themes from listener reviews, highlighting what works and what could be improved about the show.

Strong guest expertise and case-driven discussions that translate to clinic work.
Consistently up-to-date with ASH data and real-world takeaways.
High quality, practical updates for everyday decision-making in hematology-oncology.

Chart Rankings

How this podcast ranks in the Apple Podcasts, Spotify and YouTube charts.

Apple Podcasts
#169
China/Science
Apple Podcasts
#179
Saudi Arabia/Science
Apple Podcasts
#191
Brazil/Science
Apple Podcasts
#244
India/Science

Talking Points

Recent interactions between the hosts and their guests.

Myelofibrosis and Systemic Mastocytosis — Fifth Annual National General Medical Oncology Summit
Q: Can myelofibrosis be cured, and what are the advantages of earlier intervention?
The only potentially curative option is bone marrow or stem cell transplantation; JAK inhibitors can meaningfully improve symptoms and survival but are not curative, and earlier intervention—especially in intermediate-risk patients—tends to yield better spleen and symptom responses with possible survival benefits.
Chronic Lymphocytic Leukemia — Fifth Annual National General Medical Oncology Summit
Q: How do you decide between Amplify strategy using Acala with Venetoclax versus the older strategy of Obinutuzumab-Venetoclax?
My view is that all-oral regimens like Acala-venetoclax are easier to deploy and may offer similar efficacy with practical advantages, though data in certain subgroups (e.g., unmutated IGHV) may favor back-up options like Obinutuzumab-containing regimens in some scenarios; future data from MAGIC will help clarify this.
Chronic Lymphocytic Leukemia — Fifth Annual National General Medical Oncology Summit
Q: Any thoughts about the big paper of the year and papers of the year in oncology, and where do you see things heading in CLL?
The data from CLL-17 and Amplify are pivotal; they show overlapping efficacy among modern regimens and emphasize patient-centered decisions based on duration, tolerability, and MRD results. This points toward more tailored, time-limited strategies with careful patient selection and ongoing monitoring.
Diffuse Large B-Cell Lymphoma and Follicular Lymphoma — Fifth Annual National General Medical Oncology Summit
Q: With front-line options evolving, what is your take on sequencing between CAR T and bispecifics for FL patients with POD24 or high tumor burden?
For POD24 and high-risk FL, triplet regimens and frontline bispecifics offer promising activity, but CAR T may provide durable remissions in select cases; sequencing should consider safety, availability, and patient preference, keeping in mind the durability of responses.
Diffuse Large B-Cell Lymphoma and Follicular Lymphoma — Fifth Annual National General Medical Oncology Summit
Q: What are the practical differences in implementing bispecifics versus CAR T in the community, especially regarding CRS risk and outpatient management?
Bispecifics can often be delivered in outpatient settings with step-up dosing and premedication, though CRS risk and infections differ by agent; CAR T remains highly effective but requires centralized logistics and bridging therapies, with ongoing improvements in management strategies.

Audience Metrics

Listeners, social reach, demographics and more for this podcast.

Listeners per Episode
Gender Skew
Location
Interests
Professions
Age Range
Household Income
Social Media Reach

Frequently Asked Questions About Hematologic Oncology Update

What is Hematologic Oncology Update about and what kind of topics does it cover?

A clinically focused, expert-driven series that features one-on-one conversations with hematology-oncology specialists. Episodes center on the latest data and practice implications from ASH meetings, pivotal trials, and emerging therapies (BTK inhibitors, CELMoDs, ITP treatments, bispecific antibodies, CAR-T). Real-world considerations— MRD testing, sequencing of therapies, transplant timing, and toxicity management—are threaded through practical case discussions. Listeners can expect in-depth, practice-oriented insights from leading clinicians affiliated with major cancer centers, with a strong emphasis on translating trials into community care. Notably, the format often blends trial design explanations with real-world anecdotes to illustr... more

Where can I find podcast stats for Hematologic Oncology Update?

Rephonic provides a wide range of podcast stats for Hematologic Oncology Update. We scanned the web and collated all of the information that we could find in our comprehensive podcast database. See how many people listen to Hematologic Oncology Update and access YouTube viewership numbers, download stats, audience demographics, chart rankings, ratings, reviews and more.

How many listeners does Hematologic Oncology Update get?

Rephonic provides a full set of podcast information for three million podcasts, including the number of listeners. View further listenership figures for Hematologic Oncology Update, including podcast download numbers and subscriber numbers, so you can make better decisions about which podcasts to sponsor or be a guest on. You will need to upgrade your account to access this premium data.

What are the audience demographics for Hematologic Oncology Update?

Rephonic provides comprehensive predictive audience data for Hematologic Oncology Update, including gender skew, age, country, political leaning, income, professions, education level, and interests. You can access these listener demographics by upgrading your account.

How many subscribers and views does Hematologic Oncology Update have?

To see how many followers or subscribers Hematologic Oncology Update has on Spotify and other platforms such as Castbox and Podcast Addict, simply upgrade your account. You'll also find viewership figures for their YouTube channel if they have one.

Which podcasts are similar to Hematologic Oncology Update?

These podcasts share a similar audience with Hematologic Oncology Update:

1. Two Onc Docs
2. Blood Cancer Talks
3. Blood Podcast
4. The Hematologist
5. Gastrointestinal Cancer Update

How many episodes of Hematologic Oncology Update are there?

Hematologic Oncology Update launched 18 years ago and published 545 episodes to date. You can find more information about this podcast including rankings, audience demographics and engagement in our podcast database.

How do I contact Hematologic Oncology Update?

Our systems regularly scour the web to find email addresses and social media links for this podcast. We scanned the web and collated all of the contact information that we could find in our podcast database. But in the unlikely event that you can't find what you're looking for, our concierge service lets you request our research team to source better contacts for you.

Where can I see ratings and reviews for Hematologic Oncology Update?

Rephonic pulls ratings and reviews for Hematologic Oncology Update from multiple sources, including Spotify, Apple Podcasts, Castbox, and Podcast Addict.

View all the reviews in one place instead of visiting each platform individually and use this information to decide if a show is worth pitching or not.

How do I access podcast episode transcripts for Hematologic Oncology Update?

Rephonic provides full transcripts for episodes of Hematologic Oncology Update. Search within each transcript for your keywords, whether they be topics, brands or people, and figure out if it's worth pitching as a guest or sponsor. You can even set-up alerts to get notified when your keywords are mentioned.

What guests have appeared on Hematologic Oncology Update?

Recent guests on Hematologic Oncology Update include:

1. Tony Hunter
2. Abe Yacoub
3. Mian Hussein
4. Dr. John Allan
5. Dr. Adam Kittai
6. Dr. Sue Smitha-Apori
7. Manali Kamdar
8. Krish Patel

To view more recent guests and their details, simply upgrade your Rephonic account. You'll also get access to a typical guest profile to help you decide if the show is worth pitching.

Find and pitch the right podcasts

We help savvy brands, marketers and PR professionals to find the right podcasts for any topic or niche. Get the data and contacts you need to pitch podcasts at scale and turn listeners into customers.
Try it free for 7 days